Viewing Study NCT06629818


Ignite Creation Date: 2025-12-25 @ 5:03 AM
Ignite Modification Date: 2026-03-03 @ 12:24 PM
Study NCT ID: NCT06629818
Status: RECRUITING
Last Update Posted: 2025-06-03
First Post: 2024-10-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Daratumumab Combined With Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis With Translocation (11;14)
Sponsor: Peking Union Medical College Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Light Chain (AL) Amyloidosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Light Chain (AL) Amyloidosis View
None CCND1 Translocation View
None Venetoclax View
None Daratumumab View